Skip to main content

Year: 2024

Northrim BanCorp Announces Acquisition of Sallyport Commercial Finance, LLC

ANCHORAGE, Alaska, Nov. 01, 2024 (GLOBE NEWSWIRE) — Northrim BanCorp, Inc. (NASDAQ:NRIM) (“Northrim” or the “Company”) today announced the acquisition of Sallyport Commercial Finance, LLC (“Sallyport” or “SCF”) in an all cash transaction that closed on October 31, 2024 and is valued at approximately $53.9 million. Sallyport Commercial Finance, LLC is a leading provider of factoring, asset based lending and alternative working capital solutions to small and medium sized enterprises in the United States and Canada. The transaction is expected to provide earnings accretion of approximately 15% to Northrim’s 2025 operating results. “Having worked with Nick and the Sallyport team for several years, we have been impressed by the quality of the business they have built,” said Mike Huston, President and CEO of Northrim. “We view this as...

Continue reading

Merit Medical Completes Acquisition of Lead Management Portfolio from Cook Medical

SOUTH JORDAN, Utah, Nov. 01, 2024 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today reported that it has completed the acquisition of Cook Medical’s lead management portfolio. The purchase consideration consisted of a cash payment of approximately $210 million and the assumption of certain liabilities. Merit funded the acquisition payment through a combination of cash on hand and borrowings under its long-term credit facility. “We are pleased to announce the completion of this important acquisition,” said Fred P. Lampropoulos, Merit’s Chairman and Chief Executive Officer. “We are excited to welcome the talented team from Cook Medical’s lead management business. We believe this acquisition will strengthen our fast-growing, high-margin electrophysiology and CRM business,...

Continue reading

Arbe Robotics, Ltd. Announces Pricing of up to $49 Million Public Offering

$15 million upfront with up to an additional $34 million of aggregate gross proceeds upon the exercise in full for cash of long-term and milestone-linked warrants TEL AVIV, ISRAEL, Nov. 01, 2024 (GLOBE NEWSWIRE) — Arbe Robotics Ltd. (NASDAQ, TASE: ARBE) (“Arbe” or the “Company”), a global leader in Perception Radar Solutions, today announced the pricing of a public offering of an aggregate of 8,250,000 ordinary shares (or pre-funded warrants in lieu thereof) accompanied by Tranche A Warrants to purchase up to 8,250,000 ordinary shares and Tranche B Warrants to purchase up to 8,250,000 ordinary shares, at a combined public offering price of $1.82 per share (or per pre-funded warrant in lieu thereof) and accompanying Tranche A Warrant and Tranche B Warrant. The Tranche A Warrants will have an exercise price of $2.35 per share, will...

Continue reading

ASP Isotopes Announces Pricing of Public Offering of Common Stock

WASHINGTON, Nov. 01, 2024 (GLOBE NEWSWIRE) — ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”) today announced the pricing of the previously announced underwritten public offering of shares of its common stock. ASP Isotopes has agreed to sell an aggregate of 2,395,000 shares of its common stock at a public offering price of $6.75 per share. The gross proceeds to ASP Isotopes from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by ASP Isotopes, and without giving effect to any exercise of the underwriters’ option to purchase additional shares, are expected to be approximately $16.2 million. In addition, ASP Isotopes has granted the underwriters a 30-day option to purchase up to 359,250 additional shares of common stock at the public offering price,...

Continue reading

AITX’s RAD Reveals Next Generation Wheeled Security Robot

ROAMEO Gen 4ROAMEO Gen 4, the latest in autonomous security technology from AITX’s RAD, stands ready to patrol and protect with unmatched visibility and advanced AI capabilities.‘ROAMEO Generation 4’ Poised to Fulfill Broad Market Need Detroit, Michigan, Nov. 01, 2024 (GLOBE NEWSWIRE) — Robotic Assistance Devices, Inc. (RAD), a subsidiary of Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCPK:AITX), reveals the core specifications for its highly anticipated next generation wheeled robot, ROAMEO™ Generation 4 (Gen 4). After years of development, this mobile robot is scheduled for customer demonstrations beginning in March 2025. This next-generation autonomous security robot is poised to finally fill a long-needed solution in the security and facility management industries: a versatile...

Continue reading

Form 8.3 – [ECKOH PLC – 31 10 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ECKOH PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

ATA Creativity Global to Release 2024 Third Quarter Financial Results on November 7

BEIJING, Nov. 01, 2024 (GLOBE NEWSWIRE) — ATA Creativity Global (“ACG” or the “Company”, Nasdaq: AACG), an international educational services company focused on providing quality learning experiences that cultivate and enhance students’ creativity, today announced that it will release financial results for the third quarter and nine-month periods ended September 30, 2024, after the close of the stock market on Thursday, November 7, 2024. A conference call to discuss these results and management’s outlook is scheduled for 8:00 p.m. Eastern Time on Thursday, November 7 (corresponding to 9:00 a.m. Beijing Time on Friday, November 8).Participant Dial-in NumbersU.S. & Canada (Toll-Free):   (877) 407-9122International (Toll):   (201) 493-6747     China (Local Access):        (400) 120-2840Hong...

Continue reading

21Shares AG (the “Company”) – Official Notice regarding the update on the name of Exchange Traded Product

The below was filed with SIX Exchange on 30 October 2024 in accordance with applicable regulations. The original filing can be found here. Official Notice No.: 322516 Title: 21Shares AG (the “Company”) – Official Notice regarding the update on the name ofExchange Traded Product Relevant Exchange Traded Product: ETP: 21Shares Ethereum Core ETPValor Number: 12097631ISIN: CH1209763130Ticker Symbol: ETHCSettlement Currency: USDTrading Currency on SIX: USDPlace of initial listing: SIX Swiss Exchange Name, registered office and address of the Company:21Shares AG is a stock corporation under the laws of Switzerland. It has its registered office and address at Pelikanstrasse 37, 8001 Zurich. On November 19, 2024, the name of the respective Product will be changed as follows: – ISIN being CH1209763130,Old: 21Shares Ethereum...

Continue reading

Galecto Reports Third Quarter 2024 Financial Results

–  Completed strategic review to focus on oncology and severe liver diseases –  Announced acquisition of global rights to BRM-1420, a dual ENL-YEATS and FLT3 inhibitor for multiple genetic subsets of AML from Bridge Medicines –  Appointed Dr. Amy Wechsler to the Board of Directors and Matthew Kronmiller as Executive Vice President of Strategy and Chief Business Officer BOSTON, Nov. 01, 2024 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and severe liver diseases, today reported financial results for the third quarter ended September 30, 2024. “The third quarter was a pivotal period for Galecto highlighted by the completion of a strategic review to prioritize oncology and liver diseases and subsequent acquisition...

Continue reading

Offer and Prospectus

FORESIGHT ENTERPRISE VCT PLC (Company)Legal Entity Identity number: 213800MWJNR3WZZ3ZP42Offer and Prospectus The board of the Company (Board) is pleased to announce the launch of a new offer for subscription (Offer) to raise up to £20 million (with an over-allotment facility to raise up to a further £10 million) through the issue of new shares (Offer Shares). The Offer will provide shareholders and new investors with a further opportunity to invest in the Company and benefit from the VCT tax reliefs available to qualifying investors. The Offer opens today and will close for Applications at 12.00 noon on 2 April 2025 in respect of the 2024/2025 tax year and 12.00 noon on 30 April 2025 in respect of the 2025/2026 tax year (or, if earlier, as soon as the Offer is fully subscribed or otherwise at the Board’s discretion). The additional funds...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.